Covered recipient · General Payments record
LUIS D USUGA
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$25,005.41
- Reported across 188 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $340.68 | 15 |
| Education | $13.35 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SHIELD THERAPEUTICS INC | $114.46 | 2 |
| Novo Nordisk AS | $37.71 | 2 |
| Exeltis, USA Inc. | $34.74 | 2 |
| PFIZER INC. | $33.75 | 2 |
| Organon LLC | $29.82 | 2 |
| Sumitomo Pharma America, Inc. | $23.45 | 1 |
| Astellas Pharma US Inc | $23.22 | 1 |
| MIMEDX Group, Inc. | $15.71 | 1 |
| Currax Pharmaceuticals LLC | $13.94 | 1 |
| VIVUS LLC | $13.88 | 1 |
| MILLICENT US INC | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $23.22 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139337744 | CMS |
| Currax Pharmaceuticals LLC | $13.94 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089512936 | CMS |
| Exeltis, USA Inc. | $15.44 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150006540 | CMS |
| Exeltis, USA Inc. | $19.30 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150006542 | CMS |
| MILLICENT US INC | $13.35 | 11/01/2024 | Education | Undisputed | 01/23/2026 | 1150912886 | CMS |
| MIMEDX Group, Inc. | $15.71 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140271050 | CMS |
| Novo Nordisk Inc | $20.52 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096963620 | CMS |
| Novo Nordisk Inc | $17.19 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097118227 | CMS |
| Organon Llc | $6.29 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136201787 | CMS |
| Organon Llc | $23.53 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136201789 | CMS |
| PFIZER INC. | $17.48 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131602177 | CMS |
| PFIZER INC. | $16.27 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131588367 | CMS |
| SHIELD THERAPEUTICS INC | $24.15 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150129868 | CMS |
| SHIELD THERAPEUTICS INC | $90.31 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150154870 | CMS |
| Sumitomo Pharma America, Inc. | $23.45 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148930624 | CMS |
| VIVUS LLC | $13.88 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129418595 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.